[{"Assets_0_Q1_USD":1680968000.0,"CommonStockSharesOutstanding_0_Q1_shares":86054000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":34378000.0,"NetIncomeLoss_1_Q1_USD":102681000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":86204000.0,"StockholdersEquity_0_Q1_USD":51562000.0,"EarningsPerShareBasic_1_Q1_USD":1.19,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20190501"}]